Clinical Trial Update: Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating PEG-Intron (pegylated interferon alfa-2b) plus REBETOL (ribavirin) in pediatric patients with chronic hepatitis C has completed, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PEG Intron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2009-03-09